Understanding Cavernoma: Patient Perspectives and Neurorehabilitation

Did you know that approximately 1 in 625 individuals are affected by a condition known as cavernoma? This condition can lead to intracranial haemorrhage and neurological deficits, often requiring specialized neurorehabilitation. Despite its prevalence, many clinicians are unfamiliar with cavernoma, as symptomatic cases are comparatively rare, impacting only 1 in 2,700 people.

Join us for this enlightening, patient-led session featuring representatives from Cavernoma Alliance UK, a charity that advocates for over 4,000 individuals living with this condition. They will provide insights into cavernoma, highlight its effects on the lives of those affected, and discuss how clinicians can play a vital role in supporting patients on their neurorehabilitation journey.

Don't miss this opportunity to expand your knowledge and understanding of cavernoma, enhance your clinical practice, and contribute to better patient outcomes.